Delivery Order SPE2DB25D3402-SPE2DB25FUGLX
- Not listed
- The Defense Logistics Agency awarded a $15,944.25 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,143.89 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 18, 2025. This delivery order was competitively awarded without...
- The Defense Logistics Agency awarded a delivery order valued at $5,762.72 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injectors on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's existing...
- The Defense Logistics Agency awarded a $5,719.41 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The order is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections with a ceiling value of $1,797.29. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens with a contract value of $20,902.70. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,525.20. This firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $31,248.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections on August 20, 2025, with completion targeted for August 21, 2025. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $1,306.78 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 2, 2025, and performance to be executed at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,205.08 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injections on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB25FUGLXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,808.47. The delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its prime vendor agreement with DLA. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic categories to support Defense Health Agency and other government healthcare entities. This delivery order for Zepbound exemplifies the company's role in providing specialty medications to support military personnel and beneficiary healthcare needs through the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/8/25 |